Evidence map›Paper›PMID 22240811›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2012

PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress.

Tatsuyoshi Kono, Geonyoung Ahn, Dan R Moss, Liann Gann, Angel Zarain-Herzberg, Yurika Nishiki, Patrick T Fueger, Takeshi Ogihara, Carmella Evans-Molina

Open access · greenAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 117 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Endoplasmic Reticulum Stress and Obesity.Advances in experimental medicine and biology · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. CaBiomedicines · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Tatsuyoshi KonoDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Geonyoung Ahn
Dan R Moss
Liann Gann
Angel Zarain-Herzberg
Yurika Nishiki
Patrick T Fueger
Takeshi Ogihara
Carmella Evans-Molina
Indiana University School of MedicineIndiana University – Purdue University Indianapolis · USJuntendo University · JP

Funding

Mechanisms of Beta Cell Function in Health and DiseaseR01DK093954 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI EVANS-MOLINA, CARMELLA · 2011 to 2019
$3.5M
Training in Vascular Biology and MedicineT32HL079995 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MARCH, KEITH LEONARD · 2005 to 2014
$2.2M
Transcriptional Regulation of the Insulin Gene in Health and DiseaseK08DK080225 · NIDDK · UNIVERSITY OF VIRGINIA · PI EVANS-MOLINA, CARMELLA · 2007 to 2011
$701k
Transcriptional and Post-translational Dysregulation of SERCA in Type 2 DiabetesR03DK089147 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI EVANS-MOLINA, CARMELLA · 2010 to 2011
$153k
NHLBI NIH HHS T32 HL079995NIDDK NIH HHS K08 DK080225NIDDK NIH HHS R01 DK093954NIDDK NIH HHS R03 DK089147
6 · The paper itself

Abstract

The maintenance of intracellular Ca(2+) homeostasis in the pancreatic β-cell is closely regulated by activity of the sarco-endoplasmic reticulum Ca(2+) ATPase (SERCA) pump. Our data demonstrate a loss of β-cell SERCA2b expression in several models of type 2 diabetes including islets from db/db mice and cadaveric diabetic human islets. Treatment of 832/13 rat INS-1-derived cells with 25 mm glucose and the proinflammatory cytokine IL-1β led to a similar loss of SERCA2b expression, which was prevented by treatment with the peroxisome proliferator-activated receptor (PPAR)-γ agonist, pioglitazone. Pioglitazone was able to also protect against hyperglycemia and cytokine-induced elevations in cytosolic Ca(2+) levels, insulin-secretory defects, and cell death. To determine whether PPAR-γ was a direct transcriptional regulator of the SERCA2 gene, luciferase assays were performed and showed that a -259 bp region is sufficient to confer PPAR-γ transactivation; EMSA and chromatin immunoprecipitation experiments confirmed that PPAR-γ directly binds a PPAR response element in this proximal region. We next sought to characterize the mechanisms by which SERCA2b was down-regulated. INS-1 cells were exposed to high glucose and IL-1β in time course experiments. Within 2 h of exposure, activation of cyclin-dependent kinase 5 (CDK5) was observed and correlated with increased serine-273 phosphorylation of PPAR-γ and loss of SERCA2 protein expression, findings that were prevented by pioglitazone and roscovitine, a pharmacological inhibitor of CDK5. We conclude that pioglitazone modulates SERCA2b expression through direct transcriptional regulation of the gene and indirectly through prevention of CDK5-induced phosphorylation of PPAR-γ.

Indexed as

AnimalsBase SequenceBinding SitesBlood GlucoseCalciumCell CycleCyclin-Dependent Kinase 5CytokinesDiabetes Mellitus, ExperimentalDown-RegulationHumansHypoglycemic AgentsInsulinInsulin-Secreting CellsInsulin SecretionIslets of LangerhansBlood GlucoseCalciumCyclin-Dependent Kinase 5CytokinesHypoglycemic AgentsInsulinIsoenzymesPioglitazonePPAR gammaSarcoplasmic Reticulum Calcium-Transporting ATPasesThiazolidinediones

Identifiers

PMID22240811
PMCPMC3275161
OpenAlexW1986025611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.